 |
Emageon to Move Beyond
PACS
February 2004, Birmingham, AL -- Although the
big news from Emageon lately has been a flurry of new contracts
with some high profile
hospitals and IDNs, the company's focus is firmly on the future.
Given the spate of contracts - in the last two months, the company
has inked deals with Thedacare, a central Wisconsin IDN, BJC Healthcare
in St. Louis, Meriter Hospital in Madison, Wisconsin, to name just
three - one might expect Emageon to exploit its industry niche, emphasizing
sales over new development. Think again.
"We've moved beyond PACS," says Emageon Vice President
Thomas Pickard, referring to the company's new mantra of extending
imaging
across the 'ologies' - or more formally, of creating enterprise image
management systems. "This is the idea of going beyond imaging
and getting into the places that produce and distribute images."
Genesys Healthcare Vice President and CIO Dave Holland, an Emageon
customer, is unreserved in his praise.
"Emageon is out in front again with their vision for building
an 'intelligent visual medical system.' Now that we can serve clinicians
with the
movement of data, how can we assist the clinicians in the interpretation
of the data? While Emageon's current system improves clinical quality
by reducing time and costs of clinical work, the next generation
of Emageon's software will improve clinical quality by assisting
clinicians in the analysis and diagnosis of clinical data."
Of course, it's not surprising that Emageon stresses forward thinking.
The company's roots grew out of a development program at the University
of Alabama, Birmingham, in 1997. At that time, academics were trying
to provide better image access to neurosurgeons.
"They were computer scientists," Pickard says. "They
weren't even aware of the issues we talk about today."
At about the same time that Emageon was spun off as a for-profit
company, UltraVisual Medical Systems (based in Madison) was also
taking shape. The companies were a perfect complement, and worked
closely together on technology until they merged in May, 2002.
While academics are often portrayed as head-in-the-cloud thinkers,
sheltered from reality in their ivory towers, Emageon has clearly
shown that progressive thinking can give companies a head start when
new technologies emerge. In its case, the company was well situated
when two trends hit the PACS market - first, there's suddenly a greater
demand for imaging in disciplines seeking to avoid invasive surgeries.
For instance, the big news out of RSNA, Pickard notes, was the virtual
colonoscopy. That followed the information explosion created by procedures
such as breast and cardio MRs and CT angiograms.
"You're seeing a real morphing of modalities," Pickard
says. "The
only way to deal with the changes is with advanced imaging capabilities...
Referring physicians and specialists are all demanding better tools."
The second trend is a purchasing move away from departmental buys
in favor of an IT-centric approach. "It's a little more challenging
to bring all the parties into a room together," Pickard notes,
But it works in Emageon's favor, he says, because the company can
talk about the distribution of tools (which clinicians want) and
the use of open standards (which IT departments want).
The company's latest innovation is what it calls the intelligent
visual medical system. Unlike conventional PACS, Emageon's system
distributes more than images and reports - it uses thin-client technology
to move the tools to manipulate images and data to the desktops of
the clinicians who need them. The approach is winning kudos from
clients like Holland. "Emageon's strategy of building an enterprise
repository and tools to allow ... automation have been a step ahead
of the competition," he says.
Danny Meadows, director of radiology at Brookwood Hospital, said
his hospital (and three OP Dx centers), sees a similar future. "We
have just expanded to add Cath and Non-Invasive Cardiology to the
Emageon archive," he said. "Our goal is to move to a common
viewing platform for PACS, RIS, workstation, dictation, etc. This
is the way that most of the interest will move."
###
|  |